MEDBOX | Toolbox Immunization Guidelines

Orientations sur la prise en charge clinique du syndrome de thrombose-thrombocytopénie (TTS) après la vaccination contre la maladie à coronavirus 2019 (COVID-19)

Organisation Mondiale de la Santé OMS (2021) C_WHO

Orientations provisoires 19 juillet 2021

Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder,

Source: https://apps.who.int/iris/bitstream/hand

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎ (Arabic)

World Health Organization WHO (2021) C_WHO

interim guidance, 19 July 2021 (arabic version)

Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder,

Source: https://apps.who.int/iris/bitstream/hand

COVID-19 immunization in refugees and migrants: principles and key considerations: interim guidance, 31 August 2021

World Health Organization WHO (2021) C_WHO

Tags: COVID-19, vaccintion, refugee policy, migrants,

Source: https://apps.who.int/iris/bitstream/hand

Orientaciones para el manejo clínico de casos de síndrome de trombosis con trombocitopenia (‎STT)‎ tras la vacunación contra la COVID-19: orientaciones provisionales, 19 de julio de 2021

Organización Mundial de la Salud OMS (2021) C_WHO

Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder,

Source: https://apps.who.int/iris/bitstream/hand

Update 66 – COVID-19 vaccine booster doses

World Health Organization WHO (2021) CC

September 2021

Tags: booster, vaccine, COVID-19,

Source: https://cdn.who.int/media/docs/default-s

Vygen-Bonnet S, Koch J, Bogdan C, et al. (2021) C1

Epidemiologisches Bulletin 27/2021 8 Juli 2021. Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder einem der beiden zugelassenen Vektor-basierten Impfstoffe (Vaxzevria von AstraZeneca, COVID-19 Vaccine Janssen von Janssen-Cilag International). Die Impfung gegen COVID-19 soll allen Personen ab dem Alter von 18 Jahren angeboten werden. Wie im Epidemiologischen Bulletin 27/2021 ausgeführt, ändert die STIKO ihre bisherige Empfehlung einer zweimaligen (d. h. homologen) Vaxzevria-Impfung bei ≥60-Jährigen. Sie empfiehlt nunmehr auch für ≥60-Jährige ein heterologes Impfschema (d. h. 1. Impfung mit Vaxzevria gefolgt von einem mRNA-Impfstoff in einem Abstand von mindestens 4 Wochen)

Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, pediatrics, Children, Adolescents,

Source: https://www.rki.de/DE/Content/Infekt/Epi

Atualização das recomendações provisórias da OMS sobre a vacinação contra COVID-19 de gestantes e lactantes, 2 de junho de 2021

Pan American Health Organisation PAHO (2021) C_WHO

Tags: Vacinação, COVID-19, Brazil, Lactação, vacinas,

Source: https://iris.paho.org/bitstream/handle/1

World Health Organization WHO (2021) C_WHO

Tags: vaccine, COVID-19, expiry, guideline,

Source: https://apps.who.int/iris/bitstream/hand

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (‎TTS)‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎: interim guidance, 19 July 2021

World Health Organization WHO (2021) C_WHO

Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder,

Source: https://apps.who.int/iris/bitstream/hand

World Health Organization WHO (2021) C_WHO

Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to identify areas that need further attention to enable the facility to respond effectively to the pandemic. The tool encompasses key components that are essential to managing COVID-19 in a hospital setting, including: health workforce (numbers, absences, COVID-19 infections, staff vaccinated for COVID-19 health workforce management, training and support); medicines and medical supplies for management of COVID-19; IPC capacities (protocols, safety measures, guidelines) and the availability of personal protective equipment (PPE) for staff; diagnostic testing, imaging and patient monitoring devices and supplies medical equipment for management of COVID-19, including O2 administration; COVID-19 vaccine readiness ; beds and space capacity

Tags: essential health services, COVID-19, health capacity, assesment, diagnostics, Vaccines, therapeutic, hospital readiness,

Source: https://apps.who.int/iris/rest/bitstream

	Orientations sur la prise en charge clinique du syndrome de thrombose-thrombocytopénie (TTS) après la vaccination contre la maladie à coronavirus 2019 (COVID-19) Organisation Mondiale de la Santé OMS (2021) C_WHO View PDF(2) Download (2) Add to my MEDBOX Orientations provisoires 19 juillet 2021 Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder, Source: https://apps.who.int/iris/bitstream/hand
	Guidance for clinical case management of thrombosis with thrombocytopenia syndrome‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎ (Arabic) World Health Organization WHO (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX interim guidance, 19 July 2021 (arabic version) Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder, Source: https://apps.who.int/iris/bitstream/hand
	COVID-19 immunization in refugees and migrants: principles and key considerations: interim guidance, 31 August 2021 World Health Organization WHO (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Tags: COVID-19, vaccintion, refugee policy, migrants, Source: https://apps.who.int/iris/bitstream/hand
	Orientaciones para el manejo clínico de casos de síndrome de trombosis con trombocitopenia (‎STT)‎ tras la vacunación contra la COVID-19: orientaciones provisionales, 19 de julio de 2021 Organización Mundial de la Salud OMS (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder, Source: https://apps.who.int/iris/bitstream/hand
	Update 66 – COVID-19 vaccine booster doses World Health Organization WHO (2021) CC View PDF(6) Download (5) Add to my MEDBOX September 2021 Tags: booster, vaccine, COVID-19, Source: https://cdn.who.int/media/docs/default-s
	Beschluss der STIKO zur 8. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung Vygen-Bonnet S, Koch J, Bogdan C, et al. (2021) C1 View PDF(10) Download (3) Add to my MEDBOX Epidemiologisches Bulletin 27/2021 8 Juli 2021. Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder einem der beiden zugelassenen Vektor-basierten Impfstoffe (Vaxzevria von AstraZeneca, COVID-19 Vaccine Janssen von Janssen-Cilag International). Die Impfung gegen COVID-19 soll allen Personen ab dem Alter von 18 Jahren angeboten werden. Wie im Epidemiologischen Bulletin 27/2021 ausgeführt, ändert die STIKO ihre bisherige Empfehlung einer zweimaligen (d. h. homologen) Vaxzevria-Impfung bei ≥60-Jährigen. Sie empfiehlt nunmehr auch für ≥60-Jährige ein heterologes Impfschema (d. h. 1. Impfung mit Vaxzevria gefolgt von einem mRNA-Impfstoff in einem Abstand von mindestens 4 Wochen) Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, johnson&Johnson, pediatrics, Children, Adolescents, Source: https://www.rki.de/DE/Content/Infekt/Epi
	Atualização das recomendações provisórias da OMS sobre a vacinação contra COVID-19 de gestantes e lactantes, 2 de junho de 2021 Pan American Health Organisation PAHO (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Tags: Vacinação, COVID-19, Brazil, Lactação, vacinas, Source: https://iris.paho.org/bitstream/handle/1
	Guidance on utilization of COVID-19 vaccines before the date of expiry, 19 July 2021 World Health Organization WHO (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Tags: vaccine, COVID-19, expiry, guideline, Source: https://apps.who.int/iris/bitstream/hand
	Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (‎TTS)‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎: interim guidance, 19 July 2021 World Health Organization WHO (2021) C_WHO View PDF(3) Download (5) Add to my MEDBOX Tags: COVID-19, side effects, vaccination, thrombocytopenic disorder, Source: https://apps.who.int/iris/bitstream/hand
	Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19 World Health Organization WHO (2021) C_WHO View PDF(21) Download (119) Add to my MEDBOX Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to identify areas that need further attention to enable the facility to respond effectively to the pandemic. The tool encompasses key components that are essential to managing COVID-19 in a hospital setting, including: health workforce (numbers, absences, COVID-19 infections, staff vaccinated for COVID-19 health workforce management, training and support); medicines and medical supplies for management of COVID-19; IPC capacities (protocols, safety measures, guidelines) and the availability of personal protective equipment (PPE) for staff; diagnostic testing, imaging and patient monitoring devices and supplies medical equipment for management of COVID-19, including O2 administration; COVID-19 vaccine readiness ; beds and space capacity Tags: essential health services, COVID-19, health capacity, assesment, diagnostics, Vaccines, therapeutic, hospital readiness, Source: https://apps.who.int/iris/rest/bitstream

About MEDBOX

MEDBOX Video Series